Niagen Bioscience (NAGE) Proxy filing summary

Executive summary

• Annual meeting scheduled for June 24, 2026, at 3:00 pm PT in Los Angeles, CA.

• Shareholders will vote on director elections, auditor ratification, and executive compensation.

• Proxy materials and annual report are available online, with options for electronic or paper delivery.

Voting matters and shareholder proposals

• Election of eight directors is up for shareholder vote, with board recommending approval.

• Ratification of Crowe LLP as independent auditor for fiscal year ending December 31, 2026.

• Advisory vote on executive compensation as recommended by the Compensation Committee and approved by the board.

Board of directors and corporate governance

• Board recommends voting for all eight nominated directors.

• Director nominees include Frank Jaksch, Jr., Robert Fried, Steven Rubin, Wendy Yu, Gary Ng, Kristin Patrick, Ann Cohen, and Hamed Shahbazi.